| Analysis of BRCA1 and BRCA2 mutations in southern Iranian Breast cancer patients MJ Fattahi, Z Mojtahedi, N Karimaghaei, AR Talei, SJ Banani, A Ghaderi Arch Iran Med 12 (6), 584-7, 2009 | 30 | 2009 |
| Anti-nuclear antibodies in patients with polycystic ovary syndrome before and after laparoscopic electrocauterization AS Dehaghani, N Karimaghaei, ME Parsanezhad, M Malekzadeh, ... Iranian Journal of Medical Sciences 38 (2 Suppl), 187, 2013 | 19 | 2013 |
| Does Existence of Ductal Carcinoma In Situ Accompanying Invasive Ductal Carcinoma Lead to Different Clinicopathological Features and Clinical Outcome? Report of a Breast Cancer … S Tahmasebi, B Shahin, M Ghoddusi Johari, M Akrami, V Zanguri, A Talei, ... Middle East Journal of Cancer 13 (3), 472-482, 2022 | 1 | 2022 |
| Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Initial Report from Shiraz Surgical Oncology Group M Akrami, S Khezri, S Tahmasebi, MY Karami, Z Shiravani, V Zangouri, ... Middle East Journal of Cancer 13 (3), 458-465, 2022 | 1 | 2022 |
| Clinicopathological Behavior of Mucinous Breast Carcinoma in South of Iran: The Shiraz Breast Cancer Registry S Tahmasebi, MY Karami, M Akrami, V Zangouri, A Asgari, S Hosseini, ... Middle East Journal of Cancer 12 (1), 97-105, 2021 | 1 | 2021 |
| Do tumor size and biologic features interact with each other?! Which one is more important to affect breast cancer prognosis? Report of a breast cancer registry. M Akrami, M Mojarad, M Ghoddusi Johari, V Zangouri, S Tahmasebi, ... Breast Journal 26 (11), 2020 | | 2020 |
